MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE

MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE was reported 608 times

MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SURGICAL FIXATION OF RIB FRACTURE 1 0.2000
1 HOMOCYSTINAEMIA 1 0.0303
2 VASCULAR SHUNT 1 0.0172
3 INTERVENTIONAL PROCEDURE 1 0.0135
4 DEVICE PACING ISSUE 1 0.0118
5 GASTRITIS VIRAL 1 0.0076
6 PHOBIA OF DRIVING 1 0.0067
7 NEUTROPHIL TOXIC GRANULATION PRESENT 1 0.0066
8 MEDICAL DEVICE SITE REACTION 1 0.0063
9 BAND NEUTROPHIL COUNT INCREASED 1 0.0051
10 NORMAL PRESSURE HYDROCEPHALUS 2 0.0049
11 BACTERIAL DIARRHOEA 1 0.0047
12 FRONTOTEMPORAL DEMENTIA 2 0.0047
13 SALIVA DISCOLOURATION 1 0.0030
14 MULTIPLE SYSTEM ATROPHY 1 0.0028
15 RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER 1 0.0025
16 STUBBORNNESS 1 0.0023
17 NITRITE URINE PRESENT 1 0.0023
18 EATING DISORDER SYMPTOM 1 0.0022
19 WOUND NECROSIS 1 0.0021
20 AMNESTIC DISORDER 1 0.0021
21 LABELLED DRUG-FOOD INTERACTION MEDICATION ERROR 1 0.0020
22 REDUCED FACIAL EXPRESSION 2 0.0020
23 BREAST CONSERVING SURGERY 1 0.0020
24 PHYSIOTHERAPY 1 0.0019
25 AMYLOID RELATED IMAGING ABNORMALITY-MICROHAEMORRHAGES AND HAEMOSIDERIN DEPOSITS 2 0.0019
26 BODY TINEA 1 0.0018
27 REPETITIVE SPEECH 1 0.0018
28 INTRACRANIAL HAEMATOMA 1 0.0018
29 GRAFT COMPLICATION 1 0.0017
30 PLASMA CELL LEUKAEMIA 1 0.0017
31 MEAN PLATELET VOLUME INCREASED 1 0.0017
32 MEDICAL DEVICE SITE INFECTION 1 0.0016
33 ANISOCYTOSIS 1 0.0015
34 ORAL MUCOSAL DISCOLOURATION 1 0.0015
35 LYMPHOCYTE PERCENTAGE DECREASED 2 0.0015
36 THYROXINE INCREASED 1 0.0014
37 GLASSY EYES 1 0.0014
38 MONOCYTE PERCENTAGE INCREASED 1 0.0014
39 ALTERED VISUAL DEPTH PERCEPTION 1 0.0012
40 LEUKOCYTURIA 1 0.0012
41 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 2 0.0012
42 COLONIC ABSCESS 1 0.0012
43 TONGUE MOVEMENT DISTURBANCE 1 0.0012
44 DRUG TITRATION ERROR 3 0.0012
45 FOOD REFUSAL 1 0.0011
46 DRUG DOSE TITRATION NOT PERFORMED 2 0.0011
47 BONE CONTUSION 1 0.0011
48 THERAPEUTIC RESPONSE INCREASED 1 0.0011
49 DRUG DISPENSED TO WRONG PATIENT 1 0.0010
50 HYPERVIGILANCE 1 0.0010
51 SUSPECTED PRODUCT CONTAMINATION 1 0.0010
52 COMPULSIVE SHOPPING 2 0.0010
53 INNER EAR DISORDER 1 0.0009
54 BLADDER DILATATION 1 0.0009
55 NAIL GROWTH ABNORMAL 1 0.0009
56 CERVICAL VERTEBRAL FRACTURE 3 0.0009
57 PRODUCT CONTAMINATION MICROBIAL 1 0.0008
58 INTERVERTEBRAL DISC OPERATION 1 0.0008
59 LIP DISCOLOURATION 1 0.0008
60 POSTOPERATIVE WOUND COMPLICATION 1 0.0008
61 MACULAR HOLE 1 0.0007
62 NONSPECIFIC REACTION 4 0.0007
63 INFUSION SITE RASH 1 0.0007
64 SPINAL STENOSIS 3 0.0007
65 COCCYDYNIA 1 0.0007
66 MEAN CELL VOLUME DECREASED 1 0.0006
67 DEMENTIA 18 0.0006
68 TRANSCRIPTION MEDICATION ERROR 1 0.0006
69 URINE KETONE BODY PRESENT 1 0.0006
70 COLITIS MICROSCOPIC 3 0.0006
71 HALLUCINATION, VISUAL 13 0.0006
72 POSTURE ABNORMAL 2 0.0006
73 OXYGEN THERAPY 1 0.0006
74 ILLUSION 1 0.0006
75 MEDICAL PROCEDURE 1 0.0006
76 POTENTIATING DRUG INTERACTION 2 0.0006
77 CERVICAL SPINAL STENOSIS 1 0.0006
78 LOGORRHOEA 2 0.0006
79 MEAN CELL HAEMOGLOBIN DECREASED 1 0.0005
80 DISORGANISED SPEECH 1 0.0005
81 STENOSIS 1 0.0005
82 GUN SHOT WOUND 1 0.0005
83 COMMUNICATION DISORDER 2 0.0005
84 HALLUCINATION 38 0.0005
85 RENAL HAEMORRHAGE 1 0.0005
86 WALKING DISABILITY 1 0.0005
87 TORTICOLLIS 1 0.0005
88 DELUSION 7 0.0005
89 EYELID DISORDER 1 0.0004
90 FLAT AFFECT 1 0.0004
91 PATELLA FRACTURE 1 0.0004
92 STARING 1 0.0004
93 HOSPICE CARE 4 0.0004
94 ANEURYSM 2 0.0004
95 INFREQUENT BOWEL MOVEMENTS 1 0.0004
96 PERSONALITY DISORDER 1 0.0004
97 GASTROINTESTINAL MOTILITY DISORDER 2 0.0004
98 RED BLOOD CELL COUNT INCREASED 1 0.0004
99 HEART VALVE INCOMPETENCE 1 0.0003
100 PARANOIA 6 0.0003
101 PHARYNGEAL DISORDER 1 0.0003
102 FIBULA FRACTURE 1 0.0003
103 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
104 UPPER RESPIRATORY TRACT CONGESTION 1 0.0003
105 BLOOD PARATHYROID HORMONE INCREASED 1 0.0003
106 DEVICE POWER SOURCE ISSUE 1 0.0003
107 BRADYKINESIA 2 0.0003
108 THORACIC VERTEBRAL FRACTURE 1 0.0003
109 ATAXIA 4 0.0003
110 WRONG DRUG ADMINISTERED 3 0.0003
111 ANAL INCONTINENCE 3 0.0003
112 METABOLIC ENCEPHALOPATHY 1 0.0003
113 MASTICATION DISORDER 1 0.0003
114 PRE-EXISTING CONDITION IMPROVED 2 0.0003
115 BREAST CANCER RECURRENT 1 0.0003
116 POLYMYALGIA RHEUMATICA 1 0.0003
117 FACET JOINT SYNDROME 1 0.0003
118 REFUSAL OF TREATMENT BY PATIENT 2 0.0003
119 LISTLESS 1 0.0003
120 WALKING AID USER 2 0.0003
121 PSYCHOMOTOR HYPERACTIVITY 5 0.0003
122 CONFUSIONAL STATE 48 0.0003
123 WRONG PRODUCT ADMINISTERED 2 0.0003
124 ULCER HAEMORRHAGE 2 0.0003
125 NIGHTMARE 10 0.0003
126 ABNORMAL BEHAVIOUR 11 0.0003
127 MONOCYTE COUNT INCREASED 1 0.0003
128 CAROTID ARTERY OCCLUSION 1 0.0003
129 EXPIRED PRODUCT ADMINISTERED 9 0.0003
130 FREEZING PHENOMENON 1 0.0003
131 URINARY INCONTINENCE 8 0.0003
132 CARDIAC DYSFUNCTION 1 0.0003
133 PROTEIN TOTAL DECREASED 1 0.0003
134 LOSS OF CONTROL OF LEGS 1 0.0003
135 REHABILITATION THERAPY 1 0.0003
136 WOUND SECRETION 1 0.0003
137 PROSTATOMEGALY 1 0.0003
138 NAIL DISCOLOURATION 1 0.0003
139 ABNORMAL DREAMS 7 0.0003
140 DISORIENTATION 10 0.0003
141 ENURESIS 1 0.0002
142 SPINAL FUSION SURGERY 1 0.0002
143 RED BLOOD CELL COUNT DECREASED 7 0.0002
144 HYPERSOMNIA 7 0.0002
145 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
146 SUICIDAL BEHAVIOUR 1 0.0002
147 HALLUCINATIONS, MIXED 1 0.0002
148 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
149 UNRESPONSIVE TO STIMULI 6 0.0002
150 BONE CANCER 1 0.0002
151 PRODUCT DOSE OMISSION 15 0.0002
152 URINE OUTPUT DECREASED 2 0.0002
153 ONYCHOMYCOSIS 1 0.0002
154 COLD SWEAT 4 0.0002
155 WHEELCHAIR USER 1 0.0002
156 TIBIA FRACTURE 1 0.0002
157 SKIN ABRASION 1 0.0002
158 GAIT INABILITY 7 0.0002
159 RASH VESICULAR 1 0.0002
160 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
161 INABILITY TO AFFORD MEDICATION 2 0.0002
162 PRESCRIBED UNDERDOSE 4 0.0002
163 FLUID INTAKE REDUCED 1 0.0002
164 DYSPHORIA 1 0.0002
165 TOXIC EPIDERMAL NECROLYSIS 3 0.0002
166 AMMONIA INCREASED 1 0.0002
167 DEVICE RELATED INFECTION 3 0.0002
168 PRODUCT COLOUR ISSUE 1 0.0002
169 PERIPHERAL VASCULAR DISORDER 1 0.0002
170 OBESITY 3 0.0002
171 PRODUCT RESIDUE PRESENT 1 0.0002
172 BRUXISM 1 0.0002
173 HYDROCEPHALUS 1 0.0002
174 FAECALOMA 1 0.0002
175 CHOKING SENSATION 1 0.0002
176 PROSTATIC DISORDER 1 0.0002
177 DENTAL CARIES 2 0.0002
178 MENTAL STATUS CHANGES 5 0.0002
179 PERONEAL NERVE PALSY 1 0.0002
180 LETHARGY 10 0.0002
181 DYSSTASIA 5 0.0002
182 LYMPHOCYTE COUNT DECREASED 3 0.0002
183 CATARACT OPERATION 1 0.0002
184 CARDIAC PACEMAKER INSERTION 1 0.0002
185 PROTHROMBIN TIME PROLONGED 1 0.0002
186 TYPE 1 DIABETES MELLITUS 1 0.0002
187 SCHIZOPHRENIA 2 0.0002
188 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0002
189 RESTLESSNESS 6 0.0002
190 MENISCUS INJURY 1 0.0002
191 BLEPHAROSPASM 1 0.0002
192 PHOTOPSIA 1 0.0002
193 SCREAMING 1 0.0002
194 THERAPEUTIC RESPONSE UNEXPECTED 7 0.0002
195 ROTATOR CUFF SYNDROME 2 0.0002
196 TOOTH INFECTION 2 0.0002
197 APPETITE DISORDER 1 0.0002
198 EYE HAEMORRHAGE 2 0.0001
199 AGITATION 11 0.0001
200 TERMINAL STATE 1 0.0001
201 POST-TRAUMATIC STRESS DISORDER 1 0.0001
202 PRODUCT PHYSICAL ISSUE 3 0.0001
203 DROOLING 1 0.0001
204 DIVERTICULITIS 4 0.0001
205 TARDIVE DYSKINESIA 4 0.0001
206 BALANCE DISORDER 12 0.0001
207 PANIC REACTION 1 0.0001
208 HYPOKINESIA 2 0.0001
209 CRYING 5 0.0001
210 INTENTIONAL UNDERDOSE 1 0.0001
211 MAJOR DEPRESSION 1 0.0001
212 SPEECH DISORDER 7 0.0001
213 GENERAL SYMPTOM 1 0.0001
214 HEART RATE IRREGULAR 3 0.0001
215 MUSCLE TWITCHING 3 0.0001
216 PELVIC FRACTURE 1 0.0001
217 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
218 PRODUCT USE COMPLAINT 2 0.0001
219 FALL 42 0.0001
220 BLOOD ALBUMIN DECREASED 1 0.0001
221 PRODUCT PRESCRIBING ERROR 3 0.0001
222 ATRIAL FLUTTER 1 0.0001
223 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 6 0.0001
224 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
225 HIP FRACTURE 4 0.0001
226 POLYURIA 1 0.0001
227 ABNORMAL FAECES 1 0.0001
228 HICCUPS 1 0.0001
229 HYPERAESTHESIA 1 0.0001
230 SPINAL COMPRESSION FRACTURE 1 0.0001
231 POLLAKIURIA 5 0.0001
232 ANGER 4 0.0001
233 FACIAL PARALYSIS 1 0.0001
234 PRODUCT CONTAINER ISSUE 1 0.0001
235 DIZZINESS 58 0.0001
236 CARDIAC MURMUR 1 0.0001
237 DIPLOPIA 3 0.0001
238 ORTHOSTATIC HYPOTENSION 2 0.0001
239 HEART RATE DECREASED 4 0.0001
240 GASTROINTESTINAL INFECTION 1 0.0001
241 PALLOR 3 0.0001
242 MOOD ALTERED 3 0.0001
243 INCREASED TENDENCY TO BRUISE 1 0.0001
244 PRODUCT DISTRIBUTION ISSUE 1 0.0001
245 HEPATIC ENCEPHALOPATHY 1 0.0001
246 HEPATIC CIRRHOSIS 2 0.0001
247 LACERATION 1 0.0001
248 DYSARTHRIA 4 0.0001
249 SPUTUM DISCOLOURED 1 0.0001
250 BLOOD URINE PRESENT 2 0.0001
251 FEELING JITTERY 2 0.0001
252 RECALLED PRODUCT ADMINISTERED 1 0.0001
253 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1 0.0001
254 ERUCTATION 2 0.0001
255 PARKINSONISM 1 0.0001
256 VITREOUS FLOATERS 1 0.0001
257 THERAPY CHANGE 1 0.0001
258 KNEE OPERATION 1 0.0001
259 HAEMATOCRIT DECREASED 2 0.0001
260 BLADDER DISORDER 1 0.0001
261 BLOOD PRESSURE ABNORMAL 2 0.0001
262 HYPOTONIA 1 0.0001
263 SALIVARY HYPERSECRETION 1 0.0001
264 AGGRESSION 5 0.0001
265 PRODUCT ADMINISTRATION ERROR 2 0.0001
266 EYELID PTOSIS 1 0.0001
267 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 7 0.0001
268 SLUGGISHNESS 1 0.0001
269 EUPHORIC MOOD 1 0.0001
270 INITIAL INSOMNIA 1 0.0001
271 EYE DISCHARGE 1 0.0001
272 PRODUCT ODOUR ABNORMAL 1 0.0001
273 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
274 HEAD INJURY 3 0.0001
275 MEMORY IMPAIRMENT 13 0.0001
276 INCONTINENCE 1 0.0001
277 JOINT DISLOCATION 1 0.0001
278 SUDDEN DEATH 1 0.0001
279 RENAL PAIN 1 0.0001
280 EATING DISORDER 2 0.0001
281 RETCHING 2 0.0001
282 JOINT INJURY 2 0.0001
283 BODY HEIGHT DECREASED 1 0.0001
284 BIPOLAR DISORDER 1 0.0001
285 SKIN LACERATION 1 0.0001
286 BACK INJURY 1 0.0001
287 PRODUCT DISPENSING ERROR 2 0.0001
288 INTENTIONAL PRODUCT MISUSE 8 0.0001
289 GASTROINTESTINAL PAIN 1 0.0001
290 TOOTH FRACTURE 1 0.0001
291 DECREASED APPETITE 21 0.0001
292 NERVE INJURY 1 0.0001
293 INTESTINAL PERFORATION 1 0.0001
294 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
295 SEXUAL DYSFUNCTION 1 0.0001
296 SLEEP DISORDER 6 0.0001
297 COVID-19 PNEUMONIA 1 0.0001
298 NEUROLEPTIC MALIGNANT SYNDROME 1 0.0001
299 DYSPHAGIA 8 0.0001
300 CHOLECYSTITIS 1 0.0001
301 ACCIDENT 1 0.0001
302 MUSCLE RIGIDITY 1 0.0001
303 THERAPEUTIC RESPONSE DECREASED 5 0.0001
304 MUSCLE SPASTICITY 1 0.0001
305 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
306 TOOTH EXTRACTION 1 0.0001
307 SECRETION DISCHARGE 1 0.0001
308 HYPOPHAGIA 2 0.0001
309 SEIZURE 9 0.0001
310 AMNESIA 5 0.0001
311 RESPIRATORY TRACT INFECTION 2 0.0001
312 NODULE 1 0.0001
313 URINARY TRACT INFECTION 13 0.0001
314 IMMUNE SYSTEM DISORDER 1 0.0001
315 BLOOD PRESSURE DECREASED 5 0.0001
316 EAR INFECTION 2 0.0001
317 JOINT RANGE OF MOTION DECREASED 1 0.0001
318 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
319 PERIPHERAL COLDNESS 1 0.0001
320 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
321 TREMOR 12 0.0001
322 HUNGER 1 0.0001
323 APHONIA 1 0.0001
324 CARPAL TUNNEL SYNDROME 1 0.0001
325 SYNCOPE 7 0.0001
326 HYPERHIDROSIS 9 0.0001
327 RECTAL HAEMORRHAGE 3 0.0001
328 SOMNOLENCE 14 0.0001
329 MENTAL DISORDER 3 0.0001
330 APATHY 1 0.0001
331 HAEMOGLOBIN DECREASED 7 0.0001
332 VOMITING 32 0.0001
333 GAIT DISTURBANCE 13 0.0001
334 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
335 DEATH 58 0.0001
336 FEELING ABNORMAL 16 0.0001
337 IRRITABILITY 4 0.0001
338 ILL-DEFINED DISORDER 4 0.0001
339 DRUG DISPENSING ERROR 1 0.0001
340 INSURANCE ISSUE 1 0.0001
341 HIP ARTHROPLASTY 1 0.0001
342 COGNITIVE DISORDER 3 0.0001
343 SWOLLEN TONGUE 2 0.0001
344 PNEUMOTHORAX 1 0.0001
345 HALLUCINATION, AUDITORY 1 0.0001
346 CONDITION AGGRAVATED 19 0.0001
347 LOSS OF CONSCIOUSNESS 8 0.0001
348 SENSORY DISTURBANCE 1 0.0001
349 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 11 0.0001
350 CHOLELITHIASIS 2 0.0001
351 MANIA 1 0.0001
352 GENERAL PHYSICAL HEALTH DETERIORATION 7 0.0001
353 HYPOTENSION 12 0.0001
354 BLOOD UREA INCREASED 1 0.0001
355 HEMIPARESIS 1 0.0001
356 THERAPY CESSATION 3 0.0001
357 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
358 DEVICE DEFECTIVE 1 0.0001
359 NERVOUSNESS 3 0.0001
360 DEVICE USE ISSUE 1 0.0001
361 HEAD DISCOMFORT 1 0.0001
362 INSOMNIA 15 0.0001
363 CEREBRAL HAEMORRHAGE 2 0.0001
364 DIARRHOEA 36 0.0001
365 DISTURBANCE IN ATTENTION 3 0.0001
366 GASTROENTERITIS VIRAL 1 0.0001
367 TOOTHACHE 1 0.0001
368 CONSTIPATION 12 0.0001
369 RESTLESS LEGS SYNDROME 1 0.0001
370 TREATMENT NONCOMPLIANCE 3 0.0001
371 END STAGE RENAL DISEASE 1 0.0001
372 UNDERDOSE 4 0.0001
373 ACCIDENTAL OVERDOSE 2 0.0001
374 SUICIDAL IDEATION 5 0.0001
375 DRUG DOSE OMISSION 9 0.0001
376 PRODUCT DOSE OMISSION ISSUE 16 0.0001
377 DYSURIA 2 0.0001
378 THINKING ABNORMAL 1 0.0001
379 MIDDLE INSOMNIA 1 0.0001
380 DYSPNOEA EXERTIONAL 2 0.0001
381 BLOOD SODIUM DECREASED 1 0.0001
382 HYPOCALCAEMIA 1 0.0001
383 MALAISE 23 0.0001
384 DRUG PRESCRIBING ERROR 1 0.0001
385 LOWER LIMB FRACTURE 1 0.0001
386 CONTUSION 5 0.0001
387 GLAUCOMA 1 0.0001
388 DRUG INTOLERANCE 5 0.0001
389 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
390 ORAL HERPES 1 0.0001
391 ARTHRITIS 4 0.0001
392 UPPER LIMB FRACTURE 1 0.0001
393 FULL BLOOD COUNT DECREASED 1 0.0000
394 FEEDING DISORDER 1 0.0000
395 TASTE DISORDER 1 0.0000
396 VERTIGO 3 0.0000
397 RIB FRACTURE 1 0.0000
398 INCORRECT DOSE ADMINISTERED 11 0.0000
399 ASTHENIA 18 0.0000
400 CARDIO-RESPIRATORY ARREST 2 0.0000
401 FATIGUE 37 0.0000
402 KNEE ARTHROPLASTY 1 0.0000
403 PLATELET COUNT DECREASED 5 0.0000
404 WEIGHT DECREASED 13 0.0000
405 POOR QUALITY SLEEP 1 0.0000
406 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
407 FAECES DISCOLOURED 1 0.0000
408 PRODUCT PRESCRIBING ISSUE 1 0.0000
409 BLOOD PRESSURE INCREASED 7 0.0000
410 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
411 ANXIETY 13 0.0000
412 PERIPHERAL SWELLING 7 0.0000
413 GLOSSODYNIA 1 0.0000
414 ADVERSE DRUG REACTION 4 0.0000
415 PANCREATITIS ACUTE 1 0.0000
416 PRODUCT USE IN UNAPPROVED INDICATION 11 0.0000
417 PRODUCT AVAILABILITY ISSUE 1 0.0000
418 ABDOMINAL PAIN UPPER 9 0.0000
419 NEPHROLITHIASIS 2 0.0000
420 SKIN DISCOLOURATION 2 0.0000
421 RENAL DISORDER 2 0.0000
422 CARDIAC DISORDER 4 0.0000
423 NAUSEA 33 0.0000
424 BLOOD PRESSURE FLUCTUATION 1 0.0000
425 BLOOD GLUCOSE DECREASED 2 0.0000
426 HYPOGLYCAEMIA 2 0.0000
427 FIBROMYALGIA 1 0.0000
428 PRESYNCOPE 1 0.0000
429 NEURALGIA 1 0.0000
430 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
431 PNEUMONIA ASPIRATION 1 0.0000
432 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
433 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 8 0.0000
434 HOSPITALISATION 6 0.0000
435 RASH GENERALISED 1 0.0000
436 JOINT STIFFNESS 1 0.0000
437 GASTRITIS 1 0.0000
438 BRADYCARDIA 2 0.0000
439 PAIN OF SKIN 1 0.0000
440 FREQUENT BOWEL MOVEMENTS 1 0.0000
441 THROAT TIGHTNESS 1 0.0000
442 RASH PRURITIC 2 0.0000
443 WHITE BLOOD CELL COUNT DECREASED 4 0.0000
444 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
445 FEELING COLD 1 0.0000
446 INFLUENZA 4 0.0000
447 WOUND 1 0.0000
448 ABDOMINAL DISCOMFORT 6 0.0000
449 EYE PAIN 2 0.0000
450 CEREBROVASCULAR ACCIDENT 6 0.0000
451 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
452 INTENTIONAL DOSE OMISSION 1 0.0000
453 MUSCULOSKELETAL STIFFNESS 3 0.0000
454 COVID-19 6 0.0000
455 DISEASE PROGRESSION 4 0.0000
456 CATARACT 2 0.0000
457 RESPIRATORY DISORDER 1 0.0000
458 BLOOD POTASSIUM DECREASED 1 0.0000
459 JOINT SWELLING 4 0.0000
460 APHASIA 1 0.0000
461 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
462 OEDEMA PERIPHERAL 4 0.0000
463 CHEST PAIN 6 0.0000
464 FEMUR FRACTURE 1 0.0000
465 DRUG INEFFECTIVE 42 0.0000
466 WEIGHT INCREASED 7 0.0000
467 PNEUMONIA 10 0.0000
468 DEPRESSION 7 0.0000
469 IMPAIRED HEALING 1 0.0000
470 STAPHYLOCOCCAL INFECTION 1 0.0000
471 DEVICE DIFFICULT TO USE 2 0.0000
472 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
473 TYPE 2 DIABETES MELLITUS 1 0.0000
474 OFF LABEL USE 26 0.0000
475 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
476 HEPATIC ENZYME INCREASED 2 0.0000
477 CHEST DISCOMFORT 3 0.0000
478 HAEMATURIA 1 0.0000
479 ILLNESS 3 0.0000
480 DELIRIUM 1 0.0000
481 DEVICE USE ERROR 1 0.0000
482 ABDOMINAL DISTENSION 3 0.0000
483 HEADACHE 18 0.0000
484 HYPERTENSION 6 0.0000
485 THERAPY INTERRUPTED 2 0.0000
486 MOBILITY DECREASED 2 0.0000
487 PANIC ATTACK 1 0.0000
488 BRONCHITIS 2 0.0000
489 BLOOD GLUCOSE INCREASED 5 0.0000
490 MUSCULAR WEAKNESS 3 0.0000
491 BACK PAIN 6 0.0000
492 ABDOMINAL PAIN 6 0.0000
493 PLASMA CELL MYELOMA 1 0.0000
494 CHILLS 3 0.0000
495 DYSKINESIA 1 0.0000
496 BLINDNESS 1 0.0000
497 LUNG NEOPLASM MALIGNANT 1 0.0000
498 ROAD TRAFFIC ACCIDENT 1 0.0000
499 DEVICE DISLOCATION 1 0.0000
500 PRODUCT STORAGE ERROR 2 0.0000
501 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
502 DEHYDRATION 3 0.0000
503 COLITIS ULCERATIVE 1 0.0000
504 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
505 MUSCLE SPASMS 4 0.0000
506 TINNITUS 1 0.0000
507 ARTHRALGIA 9 0.0000
508 BLOOD CHOLESTEROL INCREASED 1 0.0000
509 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
510 ARRHYTHMIA 1 0.0000
511 DISEASE RECURRENCE 1 0.0000
512 MIGRAINE 2 0.0000
513 MULTIPLE SCLEROSIS 1 0.0000
514 RASH 9 0.0000
515 DYSPEPSIA 2 0.0000
516 HYPOAESTHESIA 3 0.0000
517 DRY EYE 1 0.0000
518 SINUSITIS 2 0.0000
519 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
520 PARAESTHESIA 3 0.0000
521 DRUG INTERACTION 3 0.0000
522 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
523 DRUG EFFECT DECREASED 1 0.0000
524 ARTHROPATHY 1 0.0000
525 MEDICATION ERROR 1 0.0000
526 NECK PAIN 1 0.0000
527 THROMBOCYTOPENIA 2 0.0000
528 OXYGEN SATURATION DECREASED 1 0.0000
529 FLATULENCE 1 0.0000
530 HERPES ZOSTER 1 0.0000
531 DYSPHONIA 1 0.0000
532 SURGERY 1 0.0000
533 EMOTIONAL DISTRESS 2 0.0000
534 FEELING HOT 1 0.0000
535 VISUAL IMPAIRMENT 2 0.0000
536 DYSPNOEA 9 0.0000
537 PRURITUS 6 0.0000
538 RHINORRHOEA 1 0.0000
539 DEEP VEIN THROMBOSIS 1 0.0000
540 BLOOD CREATININE INCREASED 1 0.0000
541 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
542 VISION BLURRED 2 0.0000
543 INJURY 1 0.0000
544 SKIN BURNING SENSATION 1 0.0000
545 RESPIRATORY FAILURE 1 0.0000
546 PAIN IN EXTREMITY 4 0.0000
547 EPISTAXIS 1 0.0000
548 HOT FLUSH 1 0.0000
549 PAIN 8 0.0000
550 THROMBOSIS 1 0.0000
551 INFLUENZA LIKE ILLNESS 1 0.0000
552 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
553 URTICARIA 2 0.0000
554 DRUG WITHDRAWAL SYNDROME 1 0.0000
555 GASTROINTESTINAL DISORDER 1 0.0000
556 DEVICE ISSUE 1 0.0000
557 NO ADVERSE EVENT 2 0.0000
558 ADVERSE EVENT 1 0.0000
559 OROPHARYNGEAL PAIN 1 0.0000
560 HYPERSENSITIVITY 2 0.0000
561 BREAST CANCER 1 0.0000
562 SWELLING 1 0.0000
563 PRODUCT USE ISSUE 2 0.0000
564 PULMONARY EMBOLISM 1 0.0000
565 NEUROPATHY PERIPHERAL 1 0.0000
566 ANAEMIA 2 0.0000
567 ATRIAL FIBRILLATION 1 0.0000
568 ALOPECIA 2 0.0000
569 HEART RATE INCREASED 1 0.0000
570 FLUSHING 1 0.0000
571 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
572 ERYTHEMA 2 0.0000
573 HAEMORRHAGE 1 0.0000
574 OVERDOSE 2 0.0000
575 ASTHMA 1 0.0000
576 PALPITATIONS 1 0.0000
577 RENAL FAILURE 1 0.0000
578 PRODUCT QUALITY ISSUE 1 0.0000
579 NEUTROPENIA 1 0.0000
580 COUGH 2 0.0000
581 INFECTION 1 0.0000
582 MYALGIA 1 0.0000
583 MYOCARDIAL INFARCTION 1 0.0000
584 NASOPHARYNGITIS 1 0.0000
585 INJECTION SITE PAIN 1 0.0000
586 PYREXIA 1 0.0000